A Study of a Whole-Body Balm on Newborn Babies

Inclusion Criteria: Newborn participants only: * Male or Female * 0 to 3 months old, targeting at least 15 subjects in the 0 - 28 days age range at time of enrollment. * Has Parent Participant-reported Natural Skin tone/skin Color As Follows, including: (a) Skin tones "Pale/fair to light white" and/or "White to light beige" approximately 10 participants; (b) Skin tones "Beige to light tan/light olive" and/or "Medium tan/medium olive to light brown" approximately 10 participants; (c) Skin tones "Medium brown to dark brown" and/or "Darkest brown to darkest black" approximately 10 participants * Full term (37 plus weeks of gestation, both vaginal and Caesarean mode of delivery can be included) newborn Newborn participant and parent participant: * Generally, in good health based on medical history reported by the parent participant Parent participant only: * Able to read, write, speak, and understand English * At least 18 years old and is the parent (adoptive or biological), legal guardian, and primary caregiver of the newborn participant * Has signed the informed consent document (ICD) including Health Insurance Portability and Accountability Act (HIPAA) disclosure * Intends to complete the study and is willing and able to follow all study instructions Exclusion Criteria: Newborn participant only: * Presents with a skin condition that may influence the outcome of the study or increase risk to the newborn participant (example , psoriasis, eczema, atopic dermatitis, cutaneous xerosis, erythema, or active skin cancer) * Has a family history of (defined as having a biological parent or full sibling with) eczema/atopic dermatitis * Has been bathed within 3 hours prior to Visit 1 * Has a clinical grade greater than 0 for rash/irritation, or greater than or equal to 1 for any of the other clinically assessed tolerance parameters at Visit 1 Newborn participant and parent participant: * Has known allergies or adverse reactions to common topical skincare products * Has self-reported (for the parent participant) or parent participant reported (for the newborn participant) Type 1 or Type 2 diabetes or is taking insulin or another anti-diabetic medication * Is taking a medication that would mask an AE or confound the study results, including (a) Immunosuppressive or steroidal drugs within 3 months before Visit 1; (b) Non-steroidal anti-inflammatory drugs within 5 days before Visit 1; (C) Antihistamines within 2 weeks (14 days) before Visit 1